Are we still withholding EPI in bronchoconstriction for greater than 50 year old patients? It’s not in the protocols to but I remember the memo from Feb 2021 saying to withhold it.

Is there a pharmacological benefit to administering dexamethasone PO vs IV/IM or is it the preferred route simply to avoid unnecessary sharp use? 

Why do the pandemic guidelines allow for the administration of 2 doses of epinephrine (<50y) in bronchoconstriction (asthma exacerbation) vs the ALS PCS allowing only a single dose (without age guideline)?

Does wheezing have to be present in the patient assessment to administer Ventolin?